| P2093 | author name string | Lee M | |
| | Smith BH | |
| | Francis CW | |
| | Gerich JE | |
| | Phipps RP | |
| | Taubman MB | |
| | Kaba NK | |
| | Schwarz KQ | |
| | Messing S | |
| | Mieszczanska H | |
| | Dodis R | |
| P2860 | cites work | Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes | Q44990830 |
| | Cardiovascular risk continuum: implications of insulin resistance and diabetes. | Q45937038 |
| | Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes | Q46406430 |
| | Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study | Q46553107 |
| | A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia | Q46570674 |
| | Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome | Q46801114 |
| | Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome | Q46853322 |
| | Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus | Q47909323 |
| | Insulin and risk of cardiovascular disease: a meta-analysis | Q49102279 |
| | Troglitazone improves endothelial dysfunction in patients with insulin resistance. | Q51547812 |
| | Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. | Q51556750 |
| | Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. | Q51558893 |
| | The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. | Q51567215 |
| | Resistin is an inflammatory marker of atherosclerosis in humans. | Q53870894 |
| | Improvement by the insulin-sensitizing agent, troglitazone, of abnormal fibrinolysis in type 2 diabetes mellitus. | Q54050054 |
| | Banting lecture 1988. Role of insulin resistance in human disease | Q55921416 |
| | Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Q29619886 |
| | Effects of short-term detraining on postprandial metabolism, endothelial function, and inflammation in endurance-trained men: dissociation between changes in triglyceride metabolism and endothelial function. | Q31156701 |
| | Nonhypoglycemic effects of thiazolidinediones | Q31973270 |
| | Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability | Q34023805 |
| | Thiazolidinediones | Q34346862 |
| | Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease | Q34658402 |
| | Insulin resistance as the core defect in type 2 diabetes mellitus | Q34856847 |
| | Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome. | Q34856889 |
| | Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease | Q35212563 |
| | Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes | Q35521022 |
| | Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation | Q36076678 |
| | Atherogenesis: a postprandial phenomenon | Q40237350 |
| | Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects | Q40795448 |
| | Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study | Q40881459 |
| | Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects | Q41743849 |
| | Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome1 | Q42440868 |
| | The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects | Q42526334 |
| | Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment | Q44123754 |
| | Effect of resistance exercise on postprandial lipemia. | Q44187622 |
| | Effects of low and moderate exercise intensity on postprandial lipemia and postheparin plasma lipoprotein lipase activity in physically active men. | Q44569126 |
| | The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients | Q44671845 |
| | Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus | Q44786820 |
| | Resistance exercise and postprandial lipemia: The dose effect of differing volumes of acute resistance exercise bouts | Q44911048 |
| | Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease | Q44938343 |
| | Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial | Q44953760 |
| | Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus | Q44972874 |
| P433 | issue | 5 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 942-949 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
| P1476 | title | Effects of pioglitazone on fasting and postprandial levels of lipid and hemostatic variables in overweight non-diabetic patients with coronary artery disease. | |
| P478 | volume | 5 | |